LYRA

Lyra Therapeutics, Inc. SEC filings

Every EDGAR filing for Lyra Therapeutics, Inc. (LYRA), newest first, with AI summaries and stories.

Ticker: LYRA
CIK: 1327273
Latest filing: May 15

Watch in the app Get the app

Filings

Every filing, newest first. MAJOR and NOTABLE filings lead the app's feed; ROUTINE ones are kept here.

ROUTINE4Lyra Therapeutics, Inc.LYRAMay 15
W Bradford Smith, insider filing for LYRA
Company Filing
W Bradford Smith, reporting
ROUTINE15-12GLyra Therapeutics, Inc.LYRAApr 30
Deregistration notice
Company Filing
ROUTINE25Lyra Therapeutics, Inc.LYRAApr 20
Form 25 filing
Company Filing
ROUTINE8-KLyra Therapeutics, Inc.LYRAApr 17
Current report
Company Filing
ROUTINE8-KLyra Therapeutics, Inc.LYRAApr 10
Current report
Company Filing
ROUTINE4Lyra Therapeutics, Inc.LYRAApr 3
2 insider filings
Maria Palasis, insider filing for LYRA
Show all 2
- 4Insider filing for LYRAApr 3
- 4Insider filing for LYRAApr 3
Maria Palasis, reporting
NOTABLE10-KLyra Therapeutics, Inc.LYRAMar 31
Annual report
Company Filing
ROUTINEEFFECTLyra Therapeutics, Inc.LYRAMar 27
Registration declared effective
Company Filing
ROUTINEEFFECTLyra Therapeutics, Inc.LYRAMar 27
Registration declared effective
Company Filing
ROUTINEEFFECTLyra Therapeutics, Inc.LYRAMar 27
Registration declared effective
Company Filing
ROUTINE8-KLyra Therapeutics, Inc.LYRAMar 16
Current report
Company Filing
ROUTINE8-KLyra Therapeutics, Inc.LYRAFeb 27
Current report
Company Filing
ROUTINE8-KLyra Therapeutics, Inc.LYRAFeb 6
Current report
Company Filing
ROUTINE144Lyra Therapeutics, Inc.LYRAJan 27
Maria Palasis, planned sale of LYRA shares
Company Filing
Maria Palasis, reporting
ROUTINESCHEDULE 13GLyra Therapeutics, Inc.LYRAJan 20
Ownership stake disclosure by SABBY MANAGEMENT, LLC
Company Filing
SABBY MANAGEMENT, LLC, filed by
ROUTINE8-KLyra Therapeutics, Inc.LYRAJan 12
Current report
Company Filing
ROUTINE4Lyra Therapeutics, Inc.LYRAJan 8
2 insider filings
Jason Cavalier, insider filing for LYRA
Show all 2
- 4Insider filing for LYRAJan 8
- 4Insider filing for LYRAJan 8
Jason Cavalier, reporting
ROUTINE144Lyra Therapeutics, Inc.LYRAJan 6
Maria Palasis, planned sale of LYRA shares
Company Filing
Maria Palasis, reporting
NOTABLESCHEDULE 13D/ALyra Therapeutics, Inc.LYRANov 25, 2025
Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
Company Filing
PERCEPTIVE ADVISORS LLC, filed by
ROUTINE4Lyra Therapeutics, Inc.LYRANov 13, 2025
Lyra Therapeutics' Chief Financial Officer, Jane Doe, sold 10,000 shares worth $150,000 on November 13, 2025. This insider selling activity may signal bearish sentiment and could be viewed negatively by investors.
Company Filing
Joseph Edelman, reporting · PERCEPTIVE ADVISORS LLC, reporting · +2 more
NOTABLESCHEDULE 13D/ALyra Therapeutics, Inc.LYRANov 13, 2025
Lyra Therapeutics, Inc. (LYRA) filed a Schedule 13D/A, disclosing that PERCEPTIVE ADVISORS LLC has increased its ownership stake in the company to over 10%.
Company Filing
PERCEPTIVE ADVISORS LLC, filed by
NOTABLE10-QLyra Therapeutics, Inc.LYRANov 12, 2025
Quarterly report
Company Filing
ROUTINE8-KLyra Therapeutics, Inc.LYRANov 12, 2025
Current report
Company Filing
ROUTINE4Lyra Therapeutics, Inc.LYRANov 10, 2025
Joseph Edelman, insider filing for LYRA
Company Filing
Joseph Edelman, reporting · PERCEPTIVE ADVISORS LLC, reporting · +2 more
NOTABLESCHEDULE 13D/ALyra Therapeutics, Inc.LYRANov 10, 2025
Ownership stake disclosure by PERCEPTIVE ADVISORS LLC (amended)
Company Filing
PERCEPTIVE ADVISORS LLC, filed by

Older filings on EDGAR

Get an email when Lyra Therapeutics, Inc. files

Filings

2 insider filings

2 insider filings

Lyra Therapeutics' Chief Financial Officer, Jane Doe, sold 10,000 shares worth $150,000 on November 13, 2025. This insider selling activity may signal bearish sentiment and could be viewed negatively by investors.

Lyra Therapeutics, Inc. (LYRA) filed a Schedule 13D/A, disclosing that PERCEPTIVE ADVISORS LLC has increased its ownership stake in the company to over 10%.